rent kinds of experimental data (mRNA expression, proteomics
, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.2(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining
in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.2(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.
For more information, please visit the company's web site at www.genego.com.
About Entelos, Inc.
Entelos, Inc. is a US-based life sciences company applying next-generation predictive technologies to revolutionize the way medicines are discovered, developed, and utilized. The Company leverages its proprietary in silico disease models, "virtual human" technology, and toxicology reference systems to develop safer and more effective drugs, improve the quality of health-related consumer products, and deliver on the promise of personalized medicine. Entelos provides customized products, technology and research services to global pharmaceutical, health-care, and consumer products companies in safety testing, arthritis, cardiovascular diseases, asthma, obesity, diabetes, hematopoeisis (anemia), cholesterol metabolism, skin sensitization, and personal care products.
For more information, please visit the company's web site at www.entelos.com
Page: 1 2 Related biology technology :1
. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis2
. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases3
. Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation4
. GeneGo Integrates With Cytoscape5
. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform6
. GSK Extends GeneGo License and Adds New Products7
. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant8
. VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics9
. Unilever Extends Their GeneGo MetaCore License10
. Yale Keck Microarray Center Becomes a GeneGo Center of Excellence11
. University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence